Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary IgA Nephropathy”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06687174
What this trial is testing

Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Wuhan Createrna Science and Technology Co., Ltd 72
Testing effectiveness (Phase 2)Ended earlyNCT05847920
What this trial is testing

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 53
Testing effectiveness (Phase 2)Study completedNCT03373461
What this trial is testing

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 112
Large-scale testing (Phase 3)Study completedNCT04578834
What this trial is testing

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 518
Large-scale testing (Phase 3)Study completedNCT05534919
What this trial is testing

Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301

Who this might be right for
Primary Immunoglobulin a Nephropathy (IgAN)
Everest Medicines (Singapore) Pte. Ltd. 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Not applicableLooking for participantsNCT04858724
What this trial is testing

The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)

Who this might be right for
IgA Nephropathy
Ruijin Hospital 2,000
Early research (Phase 1)Study completedNCT04887532
What this trial is testing

A Trial of HR19042 Capsule in Healthy Chinese Subjects

Who this might be right for
Primary IgA Nephropathy
Jiangsu HengRui Medicine Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT07182227
What this trial is testing

PS-002 for the Treatment of IgA Nephropathy in Adults

Who this might be right for
Immunoglobulin A (IgA) Nephropathy
Purespring Therapeutics Limited 32
Early research (Phase 1)Study completedNCT06922305
What this trial is testing

Relative Bioavailability Study of HR19042 in Healthy Subjects

Who this might be right for
Primary IgA Nephropathy; Autoimmune Hepatitis
Jiangsu HengRui Medicine Co., Ltd. 18
Post-approval studies (Phase 4)Study completedNCT04525729
What this trial is testing

Rituximab and RASi in Patients with IgAN

Who this might be right for
IgA Nephropathy
Nan Chen,MD 116
Post-approval studies (Phase 4)Looking for participantsNCT06712407
What this trial is testing

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
Calliditas Therapeutics AB 60
Large-scale testing (Phase 3)Study completedNCT03643965
What this trial is testing

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 365
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Large-scale testing (Phase 3)Looking for participantsNCT04557462
What this trial is testing

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Novartis Pharmaceuticals 540
Post-approval studies (Phase 4)Not Yet RecruitingNCT06528015
What this trial is testing

Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAProbioticsBudesonide
Gang Xu 206
Not applicableUnknownNCT00378443
What this trial is testing

ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT

Who this might be right for
Glomerulonephritis, IGA
Peking University
Testing effectiveness (Phase 2)Active Not RecruitingNCT06137768
What this trial is testing

A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 123
Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150
Large-scale testing (Phase 3)Looking for participantsNCT07014826
What this trial is testing

A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 378
Load More Results